Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is recruiting to evaluate CLDN18.2/HER2-targeted CAR-NK cells for advanced gastric cancer and advanced gastroesop…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates peripheral blood lymphocytes engineered with a murine T-cell receptor targeting the G12V mutation in…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
A clinical trial update describing a study on surgical approaches for Gastrointestinal Stromal Tumors, including tumor modeling and genomic …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
This entry reports the recruitment status of a clinical trial studying an AI model for diagnosing early gastric cancer from endoscopic image…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Identification of Therapeutic Targets in Metastatic Gastric Cancer
This clinical trial update notes ongoing recruitment for a study aiming to identify therapeutic targets in metastatic gastric cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers [Phase 2]
Phase 2 clinical trial evaluating low-dose immunotherapy for metastatic and locally advanced colorectal and gastric MSI/dMMR cancers; curren…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction [Phase 2]
A Phase 2 clinical trial update evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for locally advanced gastric …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating the anti-CEACAM5 antibody-drug conjugate M9140 in adults with advanced solid tum…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
AstraZeneca is conducting a Phase 1/2 trial to evaluate the safety of AZD6750 in adults with select advanced or metastatic solid tumors; the…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
A long-term follow-up study is being conducted for subjects enrolled in trials of Cadonilimab (AK104) for gastric cancer, with the study cur…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating conversion therapy for gastric cancer using the PD-1 inhibitor Adebrelimab plus Apatinib in combination wi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
The update details a study to collect solid tumor tissue from people undergoing biopsy or surgery for colorectal, gastric, cholangiocarcinom…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab with or without chemotherapy for locoregional MSI-H/dMMR gastric and gastroesophageal junction cancers…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
This clinical trial update describes a study evaluating fruquintinib plus albumin-bound paclitaxel with or without a PD-1 antibody as second…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas [Phase 3]
Phase 3 clinical trial investigating a combination of an immune checkpoint inhibitor for locally advanced or metastatic MSI/dMMR esogastric …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ctDNA-MRD Monitoring After Resection in Gastric Cancer
This clinical trial is evaluating ctDNA-based minimal residual disease monitoring after surgical resection in patients with gastric cancer.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma
A clinical trial update describes the planned safety and efficacy assessment of CT0494BCP in adults with advanced gastric or gastroesophagea…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. [Phase 3]
Phase 3 clinical trial using 18F-FAPI PET imaging to detect metastatic disease in patients with gastric or esophageal cancer; recruitment is…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers [Phase 3]
Phase 3 clinical trial update for zanidatamab in combination with chemotherapy with or without tislelizumab in HER2-positive advanced or met…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of a leucine-restricted diet combined with neoadjuvant chemotherapy and immunotherapy …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating IDX-1197 in combination with XELOX or Irinotecan for advanced gastric cancer. The trial is currently active but…